These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18922218)

  • 21. Long-term effect of growth hormone (GH) treatment on body composition in children with GH deficiency.
    Kuromaru R; Kohno H; Ueyama N; Hassan HM; Honda S; Hara T
    Endocr J; 1999 Mar; 46 Suppl():S35-8. PubMed ID: 12054115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Left ventricular mass and function in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
    Szczepańska Kostro J; Tołwińska J; Urban M; Głowińska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):75-80. PubMed ID: 15504309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.
    Boot AM; van der Sluis IM; Krenning EP; de Muinck Keizer-Schrama SM
    Horm Res; 2009; 71(6):364-71. PubMed ID: 19506395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of growth hormone on pediatric body composition: A systematic review.
    Ferruzzi A; Vrech M; Pietrobelli A; Cavarzere P; Zerman N; Guzzo A; Flodmark CE; Piacentini G; Antoniazzi F
    Front Endocrinol (Lausanne); 2023; 14():1093691. PubMed ID: 36843617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body composition during GH treatment in Prader-Labhardt-Willi syndrome.
    Bosio L; Beccaria L; Benzi F; Sanzari A; Chiumello G
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():351-3. PubMed ID: 10698601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency: impact on body composition, insulin sensitivity, and thyroid function.
    Jørgensen JO; Nørrelund H; Vahl N; Juul A; Skakkebaek NE; Christiansen JS
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1355-60. PubMed ID: 12510991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis.
    De Boer H; Blok GJ; Voerman HJ; De Vries PM; van der Veen EA
    J Clin Endocrinol Metab; 1992 Sep; 75(3):833-7. PubMed ID: 1517374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GH is needed for the maturation of muscle mass and strength in adolescents.
    Hulthén L; Bengtsson BA; Sunnerhagen KS; Hallberg L; Grimby G; Johannsson G
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4765-70. PubMed ID: 11600538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: a meta-analysis of placebo-controlled randomized trials.
    Newman CB; Carmichael JD; Kleinberg DL
    Pituitary; 2015 Jun; 18(3):297-305. PubMed ID: 24810900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How is whole body protein turnover perturbed in growth hormone-deficient adults?
    Hoffman DM; Pallasser R; Duncan M; Nguyen TV; Ho KK
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4344-9. PubMed ID: 9851775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study.
    Jeppesen PB; Szkudlarek J; Høy CE; Mortensen PB
    Scand J Gastroenterol; 2001 Jan; 36(1):48-54. PubMed ID: 11218239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unfavourable impact of growth hormone (GH) discontinuation on body composition and cholesterol profiles after the completion of height growth in GH-deficient young adults.
    Kohno H; Ueyama N; Honda S
    Diabetes Obes Metab; 1999 Sep; 1(5):293-6. PubMed ID: 11225641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term effects of growth hormone on body composition as a predictor of growth.
    Hoos MB; Westerterp KR; Gerver WJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2569-72. PubMed ID: 12788856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical repercussions of childhood-onset growth hormone (GH) deficiency and hGH treatment in adulthood.
    Casajús JA; Ferrández Longás A; Mayayo E; Labarta JI; Ulied MA
    J Pediatr Endocrinol Metab; 2003 Jan; 16(1):27-34. PubMed ID: 12585337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body composition, atherogenic risk factors and apolipoproteins following growth hormone treatment.
    Hassan HM; Kohno H; Kuromaru R; Honda S; Ueda K
    Acta Paediatr; 1996 Aug; 85(8):899-901. PubMed ID: 8863866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical and cardiovascular performance in cases with acromegaly after regular short-term exercise.
    Hatipoglu E; Topsakal N; Erkut Atilgan O; Camliguney AF; Ikitimur B; Ugurlu S; Niyazoglu M; Cotuk HB; Kadioglu P
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):91-7. PubMed ID: 25523748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.